摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

9H-芴-1-基甲醇 | 73728-55-9

中文名称
9H-芴-1-基甲醇
中文别名
——
英文名称
fluoren-1-yl-methanol
英文别名
1-Hydroxymethyl-fluoren;1-fluorenemethanol;(9H-fluoren-1-yl)-methanol;1-hydroxymethyl fluorene;1-hydroxymethylfluorene;9H-fluorenylmethanol;9H-fluoren-1-ylmethanol
9H-芴-1-基甲醇化学式
CAS
73728-55-9
化学式
C14H12O
mdl
——
分子量
196.249
InChiKey
OQKYEMHWZYHWBL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    15
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    20.2
  • 氢给体数:
    1
  • 氢受体数:
    1

SDS

SDS:6839e66c975fde31cf90f23d6e330b4a
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    9H-芴-1-基甲醇溶剂黄146 作用下, 生成 1-甲基芴
    参考文献:
    名称:
    February asthma outbreaks in NSW: a case control study
    摘要:
    Objectives: To investigate individual factors associated with an asthma outbreak among children aged one to 14 years in Sydney in February 1999. Methods: A case control study was undertaken with cases (n=92) defined as all children admitted to Sydney Children's Hospital for asthma in February 1999. Unmatched controls (n=76) were all children admitted for asthma in the previous three months. We obtained information by a structured telephone survey of parents. Logistic regression analyses were used to determine odds ratios for risk factors for hospital admission. Results: Mean age for hospital admission of 4.7 years for cases and 4.4 years for controls. The presence of one or more siblings reduced the risk of admission during an asthma outbreak (OR=0.59, 95% Cl 0.37 to 0.93). Children with older siblings aged 10 to 14 years were also less likely to be admitted (OR=0.3, 95% Cl 0.12 to 0.74). An age effect was observed. Other demographic, clinical and environmental characteristics, including smoking, were not associated with admission during the outbreak. Conclusions: The main findings of this study are the protective effect of siblings and an age-dependent effect in risk of hospital admission during an asthma outbreak. These findings are consistent with an infective cause of the outbreak. Implications: Children without siblings, particularly older siblings, appear to be at highest risk of hospital admission during an asthma outbreak. Environmental and other factors need to be examined to further explain the episodicity of such outbreaks and to determine means of predicting and preventing future episodes.
    DOI:
    10.1111/j.1467-842x.2001.tb00315.x
  • 作为产物:
    描述:
    芴-1-羧酸硫酸二异丁基氢化铝 作用下, 以 二氯甲烷甲苯 为溶剂, 反应 20.0h, 生成 9H-芴-1-基甲醇
    参考文献:
    名称:
    有机催化对映选择性热 [4 + 4] 环加成
    摘要:
    手性八元碳环是有机化学、天然产物化学、化学生物学和药物化学中的重要主题。缺乏构建它们的合成方法是阻碍其合理设计和立体选择性合成的挑战。催化对映选择性[4 + 4]环加成是获得手性环辛二烯衍生物的最直接和原子经济的方法之一。我们报告了 9 H的第一个有机催化不对称 [4 + 4] 环加成-fluorene-1-carbaldehydes 与缺电子二烯以良好的收率提供环辛二烯衍生物,并具有良好的周边、非对映和对映选择性控制。该反应概念基于将极化丁二烯组分纳入环状扩展 π 系统中的氨基催化形成,构象自由度受限,从而实现立体控制的 [4 + 4] 环加成。FMO 分析表明,两个反应伙伴的 HOMO 和 LUMO 类似于丁二烯。该方法允许构建装饰有各种功能的环辛二烯衍生物。环辛二烯是人工合成的,允许结构多样性证明它们在形成例如手性环丁烯或环辛烷支架方面的合成效用。DFT 计算研究揭示了反应机制,确定了对初始但可逆的
    DOI:
    10.1021/jacs.2c12750
点击查看最新优质反应信息

文献信息

  • PEPTIDE TURN MIMETICS
    申请人:Cassidy Peter Joseph
    公开号:US20110040087A1
    公开(公告)日:2011-02-17
    Peptide mimetics of structure X herein which (i) provide a wide range of sidechain functions at all sidechain positions, (ii) can be incorporated in a peptide sequence, (iii) can be readily synthesized and (iv) have a variety of conformations. There is also provided a novel process which can provide valuable intermediates in relation to production of peptide mimetics of structure X which intermediates have a high degree of chemo- and stereo-selectivity. Preferred mimetics include structures I, II, III, IV, V and VI.
    本文中的结构X的肽类拟体具有以下特点:(i) 在所有侧链位置提供广泛的侧链功能,(ii) 可以被纳入肽序列中,(iii) 可以被轻松合成,(iv) 具有多种构象。还提供了一种新的过程,可以提供与结构X的肽类拟体的生产相关的有价值的中间体,这些中间体具有高度的化学和立体选择性。首选的拟体包括结构I、II、III、IV、V和VI。
  • C1-symmetric bisphosphine ligands and their use in the asymmetric synthesis of pregabalin
    申请人:Bao Jian
    公开号:US20050228190A1
    公开(公告)日:2005-10-13
    Materials and methods for preparing (S)-(+)-3-(aminomethyl)-5-methyl-hexanoic acid and structurally related compounds via enantioselective hydrogenation of prochiral olefins are disclosed. The methods employ novel chiral catalysts, which include C 1 -symmetric bisphosphine ligands bound to transition metals.
    通过对原生手性烯烃进行对映选择性加氢制备(S)-(+)-3-(甲基)-5-甲基己酸及其结构相关化合物的材料和方法已被披露。这些方法采用了新颖的手性催化剂,其中包括与过渡属结合的C1对称双膦配体
  • BASE GENERATOR
    申请人:Eternal Chemical Co., Ltd.
    公开号:US20130172569A1
    公开(公告)日:2013-07-04
    The present invention provides a base generator having the structure of formula (1): wherein R 1 , R 2 , R 3 , R 4 , R 5 , and Y circle around (−)} are defined as in the specification. The base generator of the present invention can be used for imidization of a polyimide precursor, promoting crosslinking of epoxy monomers, or crosslinking of polyurethane or polyurea.
    本发明提供了一种具有公式(1)结构的碱发生器: 其中R1、R2、R3、R4、R5和Ycircle around (−)}如说明书中所定义。本发明的碱发生器可用于聚酰亚胺前体的酰亚胺化,促进环氧单体交联,或聚酯或聚的交联。
  • CYANOQUINOLINE DERIVATIVES
    申请人:Zhang Hesheng
    公开号:US20130225579A1
    公开(公告)日:2013-08-29
    Disclosed is a compound of formula I, a stereoisomer thereof, a cis-trans-isomer thereof, a tautomer thereof, or a mixture thereof, or a pharmaceutically acceptable salt thereof, a solvate thereof or a prodrug thereof, wherein R 1 , R 2 , R 3 and R 4 are each as defined in the present application.
    公开了一种公式I的化合物,其立体异构体,其顺反异构体,其互变异构体,或它们的混合物,或其药物可接受的盐,其溶剂化物或其前药,其中R1,R2,R3和R4各自如在本申请中定义。
  • [EN] NEW PEPTIDE-LINKED ESTER PRODRUGS ACTIVATED BY PROSTATE-SPECIFIC ANTIGEN<br/>[FR] NOUVEAUX PROMÉDICAMENTS D'ESTER À LIAISON PEPTIDIQUE ACTIVÉS PAR UN ANTIGÈNE SPÉCIFIQUE DE LA PROSTATE
    申请人:UNIV RUTGERS
    公开号:WO2018144880A1
    公开(公告)日:2018-08-09
    The present disclosure is directed to a series of target-selective chemotherapeutic ester prodrugs comprising PSA-cleavable peptides that promote the delivery of free doxorubicin and other chemotherapeutic agents into the prostate and/or prostate tumors with greater efficiency.
    本公开涉及一系列目标选择性化疗酯前药,包括促进游离阿霉素和其他化疗药物更有效地输送到前列腺和/或前列腺肿瘤的PSA可切割肽。
查看更多

同类化合物

(S)-2-N-Fmoc-氨基甲基吡咯烷盐酸盐 (2S,4S)-Fmoc-4-三氟甲基吡咯烷-2-羧酸 黎芦碱 鳥胺酸 魏因勒卜链接剂 雷迪帕韦二丙酮合物 雷迪帕韦中间体6 雷迪帕韦 雷迪帕维中间体 雷迪帕维中间体 雷尼托林 锰(2+)二{[乙酰基(9H-芴-2-基)氨基]氧烷负离子} 醋酸丁酸纤维素 达托霉素杂质 赖氨酸杂质4 试剂9,9-Dioctyl-9H-fluoren-2-amine 螺[环戊烷-1,9'-芴] 螺[环庚烷-1,9'-芴] 螺[环己烷-1,9'-芴] 螺[3.3]庚烷-2,6-二-(2',2'',7',7''-四碘螺芴) 螺-(金刚烷-2,9'-芴) 螺(环己烷-1,9'-芴)-3-酮 藜芦托素 荧蒽 反式-2,3-二氢二醇 草甘膦-FMOC 英地卡胺 苯芴醇杂质A 苯甲酸-(芴-9-基-苯基-甲基酯) 苯甲酸-(9-苯基-芴-9-基酯) 苯并[b]芴铯盐 苯并[a]芴酮 苯基芴胺 苯基(9-苯基-9-芴基)甲醇 苯(甲)醛,9H-芴-9-亚基腙 苯(甲)醛,4-羟基-3-甲氧基-,(3-甲基-9H-茚并[2,1-c]吡啶-9-亚基)腙 芴甲氧羰酰胺 芴甲氧羰酰基高苯丙氨酸 芴甲氧羰酰基肌氨酸 芴甲氧羰酰基环己基甘氨酸 芴甲氧羰酰基正亮氨酸 芴甲氧羰酰基D-环己基甘氨酸 芴甲氧羰酰基D-Β环己基丙氨酸 芴甲氧羰酰基-O-三苯甲基丝氨酸 芴甲氧羰酰基-D-正亮氨酸 芴甲氧羰酰基-6-氨基己酸 芴甲氧羰基-高丝氨酸内酯 芴甲氧羰基-缬氨酸-1-13C 芴甲氧羰基-叔丁基二甲基硅-D-丝氨酸 芴甲氧羰基-beta-赖氨酰酸(叔丁氧羰基) 芴甲氧羰基-S-叔丁基-L-半胱氨酸五氟苯基脂